At the end of the five-week treatment period, no significant changes in the percentage of metastasized/disseminated tumor cells in the lung or in the BM were detectable upon HER4 KO or tamoxifen or abemaciclib therapy (Figure 3F). This evidence concerns the gene ERBB4 and neoplasm.